CompletedNot applicableNCT02529085
PWS European Blood Bank for Infants and Controls From 0 to 48 Months
Studying Prader-Willi syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Maithe TAUBER, MDUniversity Hospital, Toulouse
- Intervention
- blood samples(other)
- Enrollment
- 215 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2017
Study locations (6)
- Unité d'Endocrinologie Pédiatrique / Université Catholique de Louvain, Brussels, Belgium
- Department of Pediatrics / Division of Endocrinology, Toulouse, Haute-Garonne, France
- Department of Endocrinology / University Children's Hospital, Essen, Germany
- Department of Pediatrics / Division of Endocrinology / Erasmus University Medical Center / Sophia Children's Hospital Rotterdam, Rotterdam, Netherlands
- Karolinska University Hospital, Stockholm, Sweden
- Metabolic & Molecular Imaging Group / MRC Clinical Sciences Centre / Imperial College London / Hammersmith Hospital, London, United Kingdom
Collaborators
European Society for Paediatric Endocrinology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02529085 on ClinicalTrials.govOther trials for Prader-Willi syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeSoleno Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07219485A Study of Pitolisant in Participants With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- RECRUITINGPHASE4NCT06901245Tirzepatide in PWS, HO and GNSOGrace Kim
- RECRUITINGNCT06877715Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGPHASE2NCT06772597A Study of Setmelanotide in Patients With Prader-Willi SyndromeRhythm Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06420297OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06144645A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSFoundation for Prader-Willi Research